Shawn Viverette Jenkins, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3616 S I 10 Service Rd W, Metairie, LA 70001 Phone: 504-838-5215 Fax: 504-838-5714 |
Rita Broughton, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4933 Wabash St, Metairie, LA 70001 Phone: 504-780-2766 Fax: 504-780-9699 |
Faith Elizabeth Faciane, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3925 N I 10 Service Rd W Ste 117, Metairie, LA 70002 Phone: 504-455-2446 |
Kendra Bradford, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6525 Park Manor Dr Apt 42, Metairie, LA 70003 Phone: 985-992-0498 |
Mikia Karion White, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2321 N Hullen St, Metairie, LA 70001 Phone: 504-941-7580 |
Sandy Hoffman, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 800 W William David Pkwy, Metairie, LA 70005 Phone: 504-493-4025 |
News Archive
Using bar-code technology with an electronic medication administration record (eMAR) substantially reduces transcription and medication administration errors, as well as potential drug-related adverse events, says a new study funded by HHS' Agency for Healthcare Research and Quality. The study is published in the May 6 issue of the New England Journal of Medicine.
A new study published in the American Journal of Transplantation reveals that there is a significant risk of serious skin cancers, including cutaneous squamous cell carcinoma and melanoma, in heart transplant patients.
Australian Medical Association Vice-President, Dr Mukesh Haikerwal, said today that dementia is set to become one of the greatest health challenges for the Australian community over the next decade.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") issued a statement on its investigation into the human use rabies vaccine manufactured by Jiangsu Yanshen Biological Technology Stock Co., Ltd.. Simcere obtained a controlling stake in Jiangsu Yanshen on October 24, 2009.
› Verified 2 days ago